![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Evaluation of Potential Virologic Resistance in HBV Polymerase Among Subjects with Persistent Viremia Following
up to 144 Weeks of Therapy with Tenofovir DF
|
|
|
Reported by Jules Levin
EAS Apr 14-18 2010 Vienna Austria
A Snow-Lampart,1 B Chappell,1 J Sorbel,1 K Borroto-Esoda1 and M Miller2
1Gilead Sciences, Inc., Durham, NC, USA, 2Gilead Sciences, Inc., Foster City, CA, USA
![](../images/042210/042210-2/image002.gif)
![](../images/042210/042210-2/image004.gif)
![](../images/042210/042210-2/image006.gif)
![](../images/042210/042210-2/image008.gif)
![](../images/042210/042210-2/image010.gif)
![](../images/042210/042210-2/image012.gif)
![](../images/042210/042210-2/image014.gif)
![](../images/042210/042210-2/image016.gif)
![](../images/042210/042210-2/image018.gif)
![](../images/042210/042210-2/image020.gif)
![](../images/042210/042210-2/image022.gif)
![](../images/042210/042210-2/image024.gif)
![](../images/042210/042210-2/image026.gif)
![](../images/042210/042210-2/image028.gif)
![](../images/042210/042210-2/image030.gif)
![](../images/042210/042210-2/image032.gif)
![](../images/042210/042210-2/image034.gif)
![](../images/042210/042210-2/image036.gif)
Reference
1. Snow-Lampart et. al. AASLD 2009, Poster #480
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|